| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 375,000 | 287,000 | 262,000 | 338,000 | | Cost of Revenue | 78,000 | 72,000 | 80,000 | 84,000 | | | Gross Profit | 297,000 | 215,000 | 182,000 | 254,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,000 | 39,000 | 34,000 | 40,000 | | Non Recurring |
-
|
-
| 1,344,000 | 1,863,000 | | Others | 144,000 | 137,000 | 159,000 | 193,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 112,000 | 39,000 | (1,355,000) | (1,842,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (35,000) | (53,000) | 281,000 | 613,000 | | Earnings Before Interest And Taxes | 77,000 | (14,000) | (1,074,000) | (1,229,000) | | Interest Expense | (8,000) | 46,000 | 18,000 | (31,000) | | Income Before Tax | 85,000 | (60,000) | (1,092,000) | (1,198,000) | | Income Tax Expense | 7,000 | (21,000) | (398,000) | (409,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 78,000 | (39,000) | (694,000) | (789,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 78,000 | (39,000) | (694,000) | (789,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $78,000 | ($39,000) | ($694,000) | ($789,000) |
|
1.00% Nasdaq 0.00%
Income Statement
